Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus

Transfusion

Volumn 57, Issue 5, 2017, Pages 1299-1303

  Loza Correa, Maria ^a   Kou, Yuntong ^a   Taha, Mariam ^a   Kalab, Miloslav ^b   Ronholm, Jennifer ^c   Schlievert, Patrick M ^d   Cahill, Michael P ^d   Skeate, Robert ^d   Cserti Gazdewich, Christine ^e   Ramirez Arcos, Sandra ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^c HEALTH CANADA   (Canada)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIMENHYDRINATE; HEMOGLOBIN; ONDANSETRON; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACUTE MYELOID LEUKEMIA; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BLOOD BANK; BLOOD TRANSFUSION REACTION; CASE REPORT; CENTRAL VENOUS CATHETER; CHILL; EPSILOMETER TEST; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; MICROBIOLOGY; NAUSEA AND VOMITING; NEUTROPENIA; PHENOTYPE; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; ADVERSE EFFECTS; LEUKEMIA, MYELOID, ACUTE; THROMBOCYTE TRANSFUSION; TRANSMISSION;

AGED; ANTI-BACTERIAL AGENTS; CENTRAL VENOUS CATHETERS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; PLATELET TRANSFUSION; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSFUSION REACTION;

EID: 85013277051     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14049     Document Type: Article

References (17)

1. Public Health Agency of Canada. Guideline for Investigation of Suspected Transfusion Transmitted Bacterial Contamination. CCDR 2008;34S1:1-8 [Internet]. [cited 2017 Jan 20]. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/08vol34/34s1/34s1-eng.php.
2. Greco C, Martincic I, Gusinjac A, et al. Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions. Transfusion 2007;47:1143–53.
3. Mack D, Bartscht K, Fischer C, et al. Genetic and biochemical analysis of Staphylococcus epidermidis biofilm accumulation. Methods Enzymol 2001;336:215–39.
4. Jacobs MR, Good CE, Lazarus HM, et al. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;46:1214–20.
5. Salgado-Pabon W, Case-Cook LC, Schilievert PM. Molecular analysis of staphylococcal superantigens. In: Ji Y, editor. Methicillin-resistant Staphylococcus aureus (MRSA) protocols. Totowa (NJ): Humana Press; 2014. p. 169–85.
6. Giantonio BJ, Alpaugh RK, Schultz J, et al. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J Clin Oncol 1997;15:1994–07.
7. Fatalities reported to FDA following blood collection and transfusion. Annual Summary for Fiscal Year 2015 [Internet]. Silver Spring (MD): Food and Drug Administration; [cited 2016 Sep 1]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf.
8. Hong H, Xiao W, Lazarus HM, et al. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood 2016;127:496-02.
9. Kou Y, Pagotto F, Hannach B, et al. Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report. Transfusion 2015;55:2384-9.
10. McDonald CP, Allen J, Roy A, et al. One million and counting: bacterial screening of platelet components by NHSBT, is it an effective risk reduction measure? [abstract 4D-S27-02]. Vox Sang 2015;109(Suppl 1):61.
11. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risk. Clin Microbiol Rev 1997;10:505-20.
12. Corey GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis 2009;48 Suppl 4:S254-9.
13. Robillard P, Delage G, Itaj NK, et al. Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection. Transfusion 2011;51:1405-11.
14. Perpoint T, Lina G, Poyart C, et al. Two cases of fatal shock after transfusion of platelets contaminated by Staphylococcus aureus: role of superantigenic toxins. Clin Infect Dis 2004;39:e106-9.
15. Greco-Stewart VS, Ali H, Kumaran D, et al. Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates. J Med Microbiol 2013;62:1051-9.
16. Hodgson SD, Greco-Stewart V, Jimenez CS, et al. Enhanced pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations. Transfusion 2014;54:461-70.
17. Ali H, Greco-Stewart VS, Jacobs MR, et al. Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units. J Med Microbiol 2014;63:884-91.